Locations:
Search IconSearch
October 14, 2019/Cancer/News & Insight

Jame Abraham, MD, FACP, Named Chair of Hematology/Medical Oncology

Renowned breast cancer researcher and editor to lead department

650×450-Jame-Abraham

Jame Abraham, MD, FACP, is the new Chair of Hematology/Medical Oncology at Cleveland Clinic.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In his new position, Dr. Abraham will recruit and develop staff, and guide the department’s focus on patient access and multidisciplinary care. He also will continue as Professor of Medicine at Cleveland Clinic Lerner College of Medicine.

Most recently, Dr. Abraham was Director of the Breast Oncology Program at Cleveland Clinic’s Taussig Cancer Institute and Co-Director of the Cleveland Clinic Comprehensive Breast Cancer Program.

“Successfully leading our Hematology/Medical Oncology Department requires a leader who excels at empathy, fosters a culture of teamwork, demonstrates emotional intelligence and believes in the vision of our institute,” says Brian Bolwell, MD, Chairman, Taussig Cancer Institute, Cleveland Clinic Cancer Center. “Dr. Abraham represents these qualities and has exhibited a passion for department and caregiver development, and elevating our national reputation.”

About Dr. Abraham

Dr. Abraham earned his medical degree from Calicut Medical College in Kerala, India. He then completed a residency at the University of Connecticut, followed by a fellowship in hematology at the National Heart, Lung, and Blood Institute and a fellowship in medical oncology at the National Cancer Institute.

He worked as Chief of Hematology/Oncology, Professor of Medicine and Bonnie Wells Wilson Distinguished Professor of Breast Cancer Research at West Virginia University before joining Cleveland Clinic in 2013.

A national principal investigator of multiple breast cancer clinical trials, Dr. Abraham has published and presented more than 200 papers. He also is Founding Editor of The Bethesda Handbook of Clinical Oncology.

Advertisement

His national breast cancer committee and leadership activities include serving as:

  • Member of the National Comprehensive Cancer Network (NCCN) Breast Cancer Committee.
  • Vice Chair of NRG Oncology’s Research Strategy Committee.
  • Member of NRG Oncology’s Breast Cancer Working Committee.
  • Vice Chair of the National Surgical Adjuvant Breast and Bowel Project (NSABP) Research Review Committee.

“I look forward to building upon Cleveland Clinic Taussig Cancer Institute’s position as a leader in hematology and medical oncology, delivering outstanding, compassionate patient care and innovative research,” says Dr. Abraham. “I am honored to serve patients who choose Cleveland Clinic for advanced cancer treatment and to support the department’s committed and passionate caregivers.”

Advertisement

Related Articles

Head and neck cancer illustration
October 6, 2025/Cancer/News & Insight
Blood-Based Assay Shows Promise for Personalizing Treatment in Head and Neck Cancer

New research demonstrates that cfDNA methylation patterns may noninvasively identify tumor hypoxia in head and neck squamous cell carcinoma

Head & neck image contouring
October 3, 2025/Cancer/News & Insight
Subspecialty Peer Review Improves Consistency, Quality and Safety in Head and Neck Radiation Therapy

Program reduces major contour changes and variations in organ-at-risk dosing across health system

Breast radiation therapy
October 2, 2025/Cancer/News & Insight
Study Confirms Breast Volume Preservation with Five-Day Radiation Therapy

No significant differences seen in breast volume loss between whole and partial breast treatment approaches

CT scan after prostate brachytherapy
October 1, 2025/Cancer/News & Insight
Clinical Outcomes for AI vs. Physician-Drawn Contours After Prostate Brachytherapy Comparable

Despite wide variations in contours, researchers find AI and physician methods yield equivalent results.

Dr. Mustafa Ali and patient
September 30, 2025/Cancer/News & Insight
Cytogenetic Response to Treatment Correlates With Long-Term Survival of Patients With Acute Myeloid Leukemia

New system refines classification of cytogenetic abnormalities at time of response assessment and their clinical significance

Social worker with patient
September 9, 2025/Cancer/News & Insight
Oncology Social Work a Lifeline in Blood Cancer Treatment

Lifetime Achievement award-winner reflects on psychosocial support and caregiver readiness

Dr. Mustafa Ali & patient
September 4, 2025/Cancer/News & Insight
Comparison of First-Line Chemotherapy for Adults with Acute Lymphoblastic Leukemia

Questions remain about the merits of asparaginase-based therapy

Ad